Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

375.56 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stryker (SYK): Buy, Sell, or Hold Post Q1 Earnings?
Since December 2024, Stryker has been in a holding pattern, posting a small return of 1.1% while floating around $376.76. 
Via StockStory
Topics Supply Chain
Exposures Supply Chain
2 Safe-and-Steady Stocks to Research Further and 1 to Approach with Caution
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Via Benzinga
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Steady growth and dividend increases over decades can make investors remarkably wealthy. 
Via The Motley Fool
Topics Economy
Exposures Economy
How Do Investors Really Feel About Stryker?
Via Benzinga
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
Via Benzinga
Earnings Scheduled For May 1, 2025
Via Benzinga
5 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stryker Receives FDA Clearance For OptaBlate System Aimed At Low Back Pain Relief: Retail’s Yet To React
OptaBlate BVNA is used in a targeted minimally invasive procedure to relieve vertebrogenic low back pain. 
Via Stocktwits
Topics World Trade
Exposures Product Safety Tariff
Recent Filing Shows That Rep. Thomas Kean Bought Over $9K Worth of Amazon.com Stock
Via Benzinga
SYK Q1 Earnings Call: Stryker Delivers Revenue Beat, Cites International Growth and Tariff Headwinds
Medical technology company Stryker (NYSE:SYK) announced better-than-expected revenue in Q1 CY2025, with sales up 11.9% year on year to $5.87 billion. Its non-GAAP profit of $2.84 per share was 4% above... 
Via StockStory
Topics Economy
Exposures Supply Chain
2 Large-Cap Stocks on Our Watchlist and 1 to Think Twice About
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
3 Healthcare Stocks to Keep an Eye On
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Billionaire Terry Smith, "the English Warren Buffett," Has 31% of His Hedge Fund's Portfolio Invested in 3 Exceptional Stocks
These longtime Fundsmith holdings are still great buys today. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today
Via Benzinga
Stryker, Lockheed Martin, Rockwell Automation And More On CNBC's 'Final Trades'
Via Benzinga
Reflecting On Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Stryker (NYSE:SYK)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Stryker (NYSE:SYK) and its peers. 
Via StockStory
Demystifying Stryker: Insights From 5 Analyst Reviews
Via Benzinga
2 S&P 500 Stocks Worth Investigating and 1 to Avoid
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
Exposures US Equities
Stryker’s (NYSE:SYK) Q1: Beats On Revenue
Medical technology company Stryker (NYSE:SYK) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 11.9% year on year to $5.87 billion. Its non-GAAP profit of $2.84 per... 
Via StockStory
Here's How Much $1000 Invested In Stryker 10 Years Ago Would Be Worth Today
Via Benzinga
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?
Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year? 
Via Investor's Business Daily
Topics Animal Testing Economy Government
Exposures Animal Testing Economy Political
Stryker (SYK) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company Stryker (NYSE:SYK) will be reporting earnings tomorrow after market close. Here’s what investors should know. 
Via StockStory
Topics Economy World Trade
Exposures Economy Tariff
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Rep. Thomas Kean Has Bought Up to $45K Worth Of Illumina Stock: Here's What You Should Know
Via Benzinga
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength. 
Via Benzinga
Topics ETFs
Top Analyst Reports For Bank Of America, Chevron & Stryker
Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corporation, Chevron Corporation, and Stryker Corporation, as well as two micro-cap stocks, Value... 
Via Talk Markets
Topics Stocks / Equities
Meritage Homes, TopBuild, Installed Building Products, Champion Homes, and Stryker Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,... 
Via StockStory
Topics Economy Government World Trade
Exposures Economy Political Tariff
What Does the Market Think About Stryker?
Via Benzinga
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings?
Although Stryker has dropped 5.3% to $335.22 per share over the past six months, it has beaten the S&P 500 by 8.6 percentage points. 
Via StockStory
Topics Stocks Supply Chain
Exposures Supply Chain US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.